Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties
QFR is the FDA product code for Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties, a class II device type, regulated under 21 CFR 864.5430. FDA's definition for this code reads: "A coagulation system for the measurement of whole blood viscoelastic properties is an in vitro diagnostic device used to evaluate blood coagulation, fibrinolysis, or both, in patients". As of , FDA records hold 8 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- QFR
- Device name
- Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties
- FDA definition
- A coagulation system for the measurement of whole blood viscoelastic properties is an in vitro diagnostic device used to evaluate blood coagulation, fibrinolysis, or both, in patients.
- Regulation
- 21 CFR 864.5430
- Device class
- Class II
- Review panel
- Hematology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 8
- Ingested recalls
- 0
Clearances, product code QFR
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code QFR| Applicant | Clearances |
|---|---|
| Hemosonics, LLC | 8 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
